Afferent Pharmaceuticals, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Afferent Pharmaceuticals, Inc. - overview
Established
2009
Location
San Mateo, CA, US
Primary Industry
Pharmaceuticals
About
Founded in 2009 and based in San Mateo, California, Afferent Pharmaceuticals is a bio-pharmaceutical company, focused on developing medicines to treat chronic pain by targeting P2X3 receptors in nerve fibers.
Current Investors
Domain Associates, Pappas Capital, New Leaf Venture Partners
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Diagnostic, Medical & Imaging Laboratories, Pharmaceutical Research & Development
Website
www.afferentpharma.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.